EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras

Jingjing Yang, Heping Zhu iD

Journal of Medicinal Chemistry · 11.09.2025 · 68 (17) · 18040-18063

DOI: 10.1021/acs.jmedchem.5c01019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 01.09.2025. Verfasst von Jingjing Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shaoxing Seventh People's Hospital (Affiliated Mental Health Center, Medical College of Shaoxing University), Shaoxing 312000…. Hauptthemen laut MEDLINE: Lysosomes, Small Molecule Libraries. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 141 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosome-targeting chimeras (LYTACs) have expanded the scope of targeted protein degradation (TPD) by enabling the selective removal of extracellular proteins that are inaccessible to proteasome-dependent strategies. This Perspective examines small-molecule and peptide ligands that interact with several representative lysosome-shuttling receptors and analyzes their structural characteristics, binding mechanisms, and therapeutic implications. We also investigate emerging efforts to exploit noncanonical endocytic pathways mediated by lysosomal membrane proteins, glycosylphosphatidylinositol (GPI)-anchored receptors, lectin receptors, solute carriers, integrins, and GPCRs for LYTAC development. Compared with macromolecular conjugates, small-molecule LYTACs exhibit improved pharmacokinetics, tissue penetration, and synthetic accessibility. We propose a mechanistically informed framework for the rational design of next-generation LYTACs, emphasizing the importance of ligand engineering and receptor selection. Finally, we critically discuss key challenges and future opportunities to optimize the specificity, efficacy, and translational potential of LYTACs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesSmall Molecule LibrariesAnimalsHumansLigandsChimera

Substanzen

LigandsSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Pharmacy, Shaoxing Seventh People's Hospital (Affiliated Mental Health Center, Medical College of Shaoxing University), Shaoxing 312000, China.
  • Department of Neurology, Center for Membrane Receptor and Brain Medicine, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang Univer…

ORCID-Profile: Heping Zhu

Förderung

  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, J., & Zhu, H. (2025). Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras. Journal of Medicinal Chemistry, 68(17), 18040-18063. https://doi.org/10.1021/acs.jmedchem.5c01019

Vancouver

Yang J, Zhu H. Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras. Journal of Medicinal Chemistry. 2025;68(17):18040-18063. doi:10.1021/acs.jmedchem.5c01019

BibTeX
@article{Yang2025,
  author = {Yang, Jingjing and Zhu, Heping},
  title = {Small-Molecule Ligands Targeting Lysosome-Shuttling Receptors and the Emerging Landscape of Lysosome-Targeting Chimeras},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {17},
  pages = {18040--18063},
  doi = {10.1021/acs.jmedchem.5c01019}
}
Kostenlos starten →